Skip to main content
Clinical Trials/NCT06079424
NCT06079424
Recruiting
Not Applicable

Risk Markers of Arterial Aging and Subsequent Risk of Cardiovascular Diseases and Beyond. The Paris Prospective Study III-2

Institut National de la Santé Et de la Recherche Médicale, France1 site in 1 country7,500 target enrollmentJune 20, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arterial Stiffness
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Enrollment
7500
Locations
1
Primary Endpoint
carotid diameter
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.

Detailed Description

Since May 2008, PPS3 is being following the CVD morbidity of 10157 healthy volunteers aged 50-75 years at baseline. In PPS3-2, we plan to re-invite survivors and volunteers of PPS3 to undergo a second physical examination. In particular, they will undergo a second high-precision carotid echotracking to measure vascular aging parameters and baroreflex sensitivity, permitting to study their respective dynamics. They will also underwent for the first time ultra fast echo of the radial artery to measure vascular aging parameters of the medium-sized arteries. According to fundings, blood samples will be taken and stored at -80°C in the whole population or in a subsample.

Registry
clinicaltrials.gov
Start Date
June 20, 2025
End Date
December 1, 2033
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Being enrolled in PPS3 and having signed an informed consent for PPS3-2

Exclusion Criteria

  • Institutionalized participants
  • Participants under guardianship
  • Participants under judicial safeguard measure

Outcomes

Primary Outcomes

carotid diameter

Time Frame: by 2027

high precision carotid echo tracking diameter in mm

intima media thickness

Time Frame: by 2027

high precision echo tracking intima media thickness of the common carotid artery in mm

carotid plaques

Time Frame: by 2027

high precision carotid echo tracking carotid plaques

elastic modulus

Time Frame: by 2027

high precision carotid echo tracking Young's elastic modulus, 10-3\*kPa

pulse wave velocity

Time Frame: by 2027

high precision carotid echotracking pulse wave velocity, m/s

carotid wall stress

Time Frame: by 2027

high precision carotid echotracking circumferential wall stress in kPa

wall cross sectional area

Time Frame: by 2027

high precision carotid echo tracking carotid wall cross sectional area, mm2

pulse pressure

Time Frame: by 2027

high precision carotid echotracking pulse pressure in mmHg

distensibility coefficient

Time Frame: by 2027

high precision carotid echo tracking distensibility coefficient in 10-3/kPa

stiffness

Time Frame: by 2027

high precision carotid echotracking Beta stiffness index

Secondary Outcomes

  • wall cross sectional area of the radial artery(by 2027)
  • brachial artery diameter(by 2027)
  • thickness of the intima media of the radial artery(by 2027)
  • distensibility of the radial artery(by 2027)
  • wall stress of the radial artery(by 2027)
  • arterial plaques(by 2027)
  • elastic modulus of the radial artery(by 2027)
  • pulse wave velocity of the radial artery(by 2027)
  • stiffness index of the radial artery(by 2027)
  • pulse pressure of the radial artery(by 2027)

Study Sites (1)

Loading locations...

Similar Trials